AstraZeneca's Alexion takes NMOSD awareness campaign long-form in new film highlighting community “In the U.K., 3.5 million people live with a rare disease; it’s estimated that 75% of those ...

Alexion, AstraZeneca Rare Diseasehas launcheda new electronic storybook (e-book) to support children living with rare kidney disease, atypical Haemolytic Uraemic Syndrome (aHUS). The interactive ...

2025--(BUSINESS WIRE)--Alexion, AstraZeneca Rare Disease has launched a new electronic storybook (e-book) to support children living with rare kidney disease, atypical Haemolytic Uraemic Syndrome ...

Recognising that challenge, AstraZeneca's rare disease unit Alexion has launched an interactive storybook that can help children with rare kidney disease atypical haemolytic uraemic syndrome (aHUS ...

Marc Dunoyer, CEO of AstraZeneca's rare disease group Alexion, told Fierce Biotech at a press conference Thursday morning in London that Alexion “is not immune to the odds of the industry ...

The interactive fantasy e-book "Revealing the Secrets of aHUS" puts young children at the centre of the story as they explore and learn with their families about atypical Haemolytic Uraemic Syndrome ...

Lauren Drouin is the director of analytical development and the Genomic Medicine Unit at Alexion AstraZeneca Rare Disease. As a dynamic scientist with unique expertise in current research and industry ...

The proposed acquisition will bolster the Alexion, AstraZeneca Rare Disease late-stage pipeline and expand on its bone metabolism franchise with the addition of eneboparatide (AZP-3601), a Phase 3 ...

From the brink of Nasdaq delisting last year due to non-compliance with the minimum bid price rule, this clinical-stage biotechnology ...